Detalhe da pesquisa
1.
Randomized, multicenter, open-label phase II study of gemcitabine plus single-dose versus split-dose carboplatin in the treatment of patients with advanced-stage non-small-cell lung cancer.
Clin Lung Cancer;
8(2): 135-9, 2006 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17026815